Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · IEX Real-Time Price · USD
16.14
-0.69 (-4.10%)
Apr 19, 2024, 4:30 PM EDT - Market closed
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $15.68 billion as of April 19, 2024.
Market Cap
15.68B
Enterprise Value
15.68B
1-Year Change
n/a
Ranking
Category
Stock Price
$16.14
Market Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has increased from $356.10M to $15.68B, an increase of 4,303.49%. That is a compound annual growth rate of 5,155,342,711,226,246,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 18, 2024 | 476.20M | -2.26% |
| Apr 17, 2024 | 487.20M | 6.84% |
| Apr 16, 2024 | 456.00M | 25.00% |
| Apr 15, 2024 | 364.80M | 0.69% |
| Apr 12, 2024 | 362.30M | 1.74% |
| Apr 11, 2024 | 356.10M | - |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hologic | 17.65B |
| Waters | 17.65B |
| BioMarin Pharmaceutical | 16.83B |
| Laboratory Corporation of America Holdings | 16.83B |
| Walgreens Boots Alliance | 15.52B |
| BeiGene | 14.55B |
| Teva Pharmaceutical | 14.47B |
| Quest Diagnostics | 14.20B |